Posts in tag

osteoarthritis


There is good evidence for the use of topical preparations to manage inflammation and pain in musculoskeletal conditions including soft tissue injuries; localised soft tissue rheumatism and localised forms of …

Management of osteoarthritis continues to evolve. Emerging therapies contribute to the growing body of evidence that informs treatment and management. To provide evidence-informed advice and education, pharmacists need to be …

Debbie Rigby rounds up the latest in research news Approach to schizophrenia Schizophrenia is the most common of a group of psychotic disorders that occur in approximately 3% of the …

Debbie Rigby takes a look at the latest in research news Intravenous ferric derisomaltose in patients with heart failure and iron deficiency in the UK (IRONMAN) For patients with heart …

The number of Australians living with arthritis continues to grow, while medication myths and knowledge gaps can delay diagnosis and hinder treatment One in seven Australians live with arthritis. This …

Wearing stable, supportive footwear reduces knee pain significantly in patients with severe knee osteoarthritis, according to results of a randomised, controlled trial1 presented at the OARSI 2021 World Congress. Clinical …

Debbie Rigby rounds up the latest in research news Regular use of proton pump inhibitors and risk of type 2 diabetes A prospective analysis over 200,000 participants shows an association …

In this video, Professor Andrew McLachlan discusses how a patient’s health literacy can impact their choice of self-management strategies for OA symptoms and how a lack of condition awareness can …

A recent study found only 3.5% of participants with self-reported OA symptoms sought advice from a pharmacist despite the critical role pharmacists play in helping patients on their pain management …

Osteoarthritis (OA) is a leading cause of disability that affects more than 3 million Australians. At APP 2021, Professor David Hunter, Florance and Cope Chair of Rheumatology, Professor of Medicine, the University of Sydney spoke …

Debbie Rigby takes a look at the latest in research news  Risk Versus Benefit of Combined Aspirin and Warfarin Therapy in Patients With Atrial Fibrillation In this retrospective, cohort study …

Debbie Rigby rounds up the latest in research news Amiodarone in the aged Amiodarone is a highly effective antiarrhythmic drug, but can have serious adverse effects, particularly in older patients. …